UAMS BioVentures Company Set To Go Public

by Mark Friedman  on Monday, Apr. 22, 2013 12:00 am  

Cyto Wave Technologies hopes to use this iV3 prototype to detect and kill cancer cells.  Vladimir Zharov, inset, developed the device with others

A University of Arkansas for Medical Sciences' BioVentures company that says it has a treatment that will detect and kill cancer cells is preparing to have its initial public offering.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.

Search

Most Read

    GAPI: Failed to authenticate user. Error: "https://developers.google.com/accounts/docs/AuthForInstalledApps "

Latest Arkansas Business Poll

Would you support Amendment 82 bonds for Lockheed Martin?